Hofmeister Robert 4
4 · TCR2 THERAPEUTICS INC. · Filed Nov 2, 2020
Insider Transaction Report
Form 4
Hofmeister Robert
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2020-10-29$0.74/sh+20,000$14,800→ 58,850 total - Sale
Common Stock
2020-10-29$19.10/sh−20,000$382,000→ 38,850 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-10-29−20,000→ 22,346 totalExercise: $0.74From: 2018-12-07Exp: 2027-12-07→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on by the reporting person.
- [F2]25% of this option vested and become exercisable on December 7, 2018, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.